latrepirdine (Dimebon, dimeboline, dimebolin)

From Aaushi
Jump to navigation Jump to search

Indications

Dosage

oral agent

Adverse effects

Mechanism of action

Clinical trials

  • CONNECTION trial

More general terms

References

  1. Doody RS et al, Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to- moderate Alzheimer's disease: A randomised, double-blind, placebo-controlled study. Lancet 2008, 372:207 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18640457
  2. LA Times, March 4, 2010 http://latimesblogs.latimes.com/booster_shots/2010/03/dimebon-alzheimers-disease-drug.html
  3. Pfizer Press Release Pfizer And Medivation Announce Results From Two Phase 3 Studies In Dimebon (latrepirdine*) Alzheimer's Disease Clinical Development Program http://www.pfizer.com/news/press_releases/pfizer_press_releases.jsp?rssUrl=http://mediaroom.pfizer.com/portal/site/pfizer/index.jsp
  4. Dimebon Clinical Trials http://www.dimebontrials.com

Database